Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas
Findings may create immunotherapy options for lymphomas caused by CREBBP mutationsCredit: University of Texas M.D. Anderson Cancer Center HOUSTON -- ...